<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Experimental Medicine</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D73BBDCD-FBE2-4451-A33F-FA9B449787F6"><gtr:id>D73BBDCD-FBE2-4451-A33F-FA9B449787F6</gtr:id><gtr:firstName>Timothy</gtr:firstName><gtr:otherNames>Maximilian</gtr:otherNames><gtr:surname>Walker</gtr:surname><gtr:orcidId>0000-0003-0421-9264</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ011398%2F1"><gtr:id>C7A5EF6C-BEB6-4715-BDE4-18852E417EB7</gtr:id><gtr:title>Identifying Mycobacterium tuberculosis transmissions using whole-genome sequences</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/J011398/1</gtr:grantReference><gtr:abstractText>Tuberculosis has infected a third of the world's population (2 billion people) and is responsible for 1.7 million deaths a year. 

We plan to take advantage of new rapid technology that will turn the total genetic code of greater than 4 million DNA molecules from each germ into a barcode. This will be enormously valuable to the detective work of investigating how germs are spreading from person to person. Once we can do that we'll benefit from being able to identify outbreaks of disease quicker so that earlier intervention can be arranged. 

The same technique of looking at the germ's barcode can be used to answer wider scientific questions about its evolutionary success both nationally and internationally.</gtr:abstractText><gtr:technicalSummary>Aims:
I plan to use Whole Genome Sequencing (WGS) to undertake a genealogical investigation of M tuberculosis (MTB) isolates in a high incidence region of the UK in order to further refine clusters of disease as defined by the current gold standard 24-locus MIRU-VNTR typing. I have 3 aims:
(i) I will investigate the distribution of M tuberculosis genome-wide sequence diversity within active cases across space (isolates from different anatomical loci), time (sequential isolates from individuals with a persistent infection) and household outbreaks. This data will be used to estimate the range of times to the most recent common ancestor (MRCA) of these samples which are known to be related (akin to &amp;quot;transmission&amp;quot;). 
(ii) Using results from (i) to provide thresholds for determining whether recent transmission is plausible, I will estimate most likely times to the MRCA within groups defined by 24-locus MIRU-VNTR, and use the 95% credible intervals from Bayesian phylogenetic methods to subdivide groups into clusters credibly representing recent transmission of tuberculosis.
(iii) I will then compare these genealogically identified clusters with those identified by the public health team using standardised epidemiological and demographic questionnaires.

Methods:
(i) I will sequence further samples and use Bayesian statistics to estimate the range of time to the MRCA 
(ii) I will analyse 4-5 years' worth of whole-genome sequenced samples (~ 2000 samples) from central Birmingham, and a further 250 samples from the MIRU-VNTR groups across the Midlands, using classical statistics. 

Opportunities:
(a) Translational: This study will provide a pathway for the implementation of these techniques into routine service. 
(b) Scientific: Robust genealogical analyses will provide a technique to better investigate the incubation period and transmission dynamics (including the possibility of super-spreaders), and provide a foundation for model base transmission analyses.</gtr:technicalSummary><gtr:potentialImpactText>The range of beneficiaries from this research project will be wide.

1. Decision making bodies:
(a) In the future, it may yield valuable information about the burden of on-going transmission in any region world-wide.
Time: 5-10 years
(b) At a national level the results will be of interest to policy makers in the Department of Health and HPA (now re-named and incorporated into the DoH) as they will make decisions about resource allocation to public health
Time scale: 5 years
(c) At a regional level the health protection units are likely in the future to start using WGS data rather than MIRU-VNTR typing to map transmission
Time scale: 3-5 years

2. Practitioners
(a) TB cluster investigators will be able to guide their investigations on the basis of links drawn by the WGS data
Time scale: 3-5 years
(b) Clinicians' decisions in the future may be benefited from a wider application of WGS not only to transmission networks but to resistotyping. 
Time scale: 5-10 years

3. Academics
(a) This will be of value to TB epidemiologists investigating patterns (e.g. incubation period) and routes of transmission
Time scale: Immediately
(b) These techniques could be turned to investigating the association between genotypes and phenotypes such as hyper-transmissibility or hyper-virulence. 
Time scale: 5-10 years

4. Patients
(a) New cases will be prevented if transmission is interrupted
Time scale: 3-5 years
(b) When informing patients about how they got tuberculosis this will give reassuring levels of accuracy 
Time scale: 3-5 years</gtr:potentialImpactText><gtr:fund><gtr:end>2015-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>196068</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited talk at the Wellcome Trust Applied Bioinformatics in Public Health conference, Sanger</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>152A5B44-6A37-4FF8-922F-F7D27E002893</gtr:id><gtr:impact>Invitied speaker this Wellcome Trust conference in Cambridge, 15-17th May 2013
Title: Targeted contact tracing in M. tuberculosis - how next generation sequencing can help

Useful interactions with other delegates at this socialist conference.</gtr:impact><gtr:outcomeId>GDb5Q6yo2cs</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:url>https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=313</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to Yorkshire and Humberside TB physicians, TB nurse and public health teams</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9CDB12CF-C45D-4EF5-91A9-46F77C66F2CA</gtr:id><gtr:impact>40+ TB nurses, TB physicians, microbiologists and local Health Protection Staff attended this 'TB masterclass' for Yorkshire and Humberside. The talk was aimed at explaining ho these new developments (whole-genome sequencing of TB for the purpose of surveillance) will impact on their working lives in the near future.

On-going communication.</gtr:impact><gtr:outcomeId>ScLKso4yeHE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar at the MRC Clinical Trials Unit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7D41D9B8-1FE3-455A-988C-E4070CAE9B5E</gtr:id><gtr:impact>Lunch time seminar to the CTU
Title: Whole genome sequencing of mycobacteria: applications in diagnostics and public health

Useful interactions after talk</gtr:impact><gtr:outcomeId>jDtFz9ifCF4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Oxford Modernising Medical Microbiology Public Patient Engagement</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>41EA68EF-91A1-40C8-8F68-FB7C22338703</gtr:id><gtr:impact>I gave a short talk, as did others, and then led a discussion group. These now occur several times a year.

The group made up of members of the public will continue to meet independently of out direct facilitation to discuss ideas they feel are important and warrant further research.</gtr:impact><gtr:outcomeId>546312940d6d39.84451059</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar in Marseille at the faculty of medicine</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3EFF290E-B8D3-4C8F-8127-CFE1BCD88853</gtr:id><gtr:impact>Invited to speak at the weekly seminar in Marseille's faculty of medicine.
Title: Whole genome sequencing of mycobacteria: one test to replace all?

Useful interactions before and after talk</gtr:impact><gtr:outcomeId>HAVeCNuRfsf</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Address to the Public Health England board meeting 2014</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3055517D-E10D-4472-A812-B5C56039845C</gtr:id><gtr:outcomeId>546313b06fe562.59175391</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Presentation to HPA board and all 4 CMOs: Whole-genome sequencing of M. tuberculosis as a diagnostic tool and to monitor outbreaks</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0714A286-C031-4EAA-92B4-DA307960E75B</gtr:id><gtr:outcomeId>HKadDHpeNFX</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>I developed an algorithm that relates genotype to phenotype in TB and predicts which mutations in the genome underlie phenotypic resistance. The results have been implemented into the routine PHE diagnostic service and the method underlies iterative updates to the knowledge-base upon which that service relies. The method was published int he Lancet ID in 2015, with me updating the knowledge-base since.</gtr:description><gtr:id>27B6A359-CC9D-4953-AB6C-213344D555B6</gtr:id><gtr:impact>It is the basis for the PHE WGS-based resistance predictions in TB</gtr:impact><gtr:outcomeId>58c5465ba7d3b0.32203908</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>My algorithm to identify new resistance determining mutations in TB has been incorporated into the routine diagnostic service in PHE</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>https://www.ncbi.nlm.nih.gov/pubmed/26116186</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A3E6F318-C0A5-4783-BEA6-8D930DD94A27</gtr:id><gtr:title>Mycobacterial DNA extraction for whole-genome sequencing from early positive liquid (MGIT) cultures.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0347ea9d1a0409ca2bf2a8ba6ca34273"><gtr:id>0347ea9d1a0409ca2bf2a8ba6ca34273</gtr:id><gtr:otherNames>Votintseva AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>56d9df4dda6b55.37819598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4D4DCB8-A2D2-4963-8E3B-5C129AC82F0D</gtr:id><gtr:title>Evaluation of Whole-Genome Sequencing for Mycobacterial Species Identification and Drug Susceptibility Testing in a Clinical Setting: a Large-Scale Prospective Assessment of Performance against Line Probe Assays and Phenotyping.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99cc164b1a1c68ba403d3cc0aaeeecbe"><gtr:id>99cc164b1a1c68ba403d3cc0aaeeecbe</gtr:id><gtr:otherNames>Quan TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>5a6f309295ae29.14517266</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6ACE50E9-EC29-4161-BE2E-9FE047638F5C</gtr:id><gtr:title>Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a55bddf6b58a982ce4fa44d9b7c98601"><gtr:id>a55bddf6b58a982ce4fa44d9b7c98601</gtr:id><gtr:otherNames>Pankhurst LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>56d9df4d720f82.37480447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FA96A45-C3B7-49A9-8349-9B96CFA5B708</gtr:id><gtr:title>Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b28d0b8d761f7bc1fdd65850bb4ea8f"><gtr:id>8b28d0b8d761f7bc1fdd65850bb4ea8f</gtr:id><gtr:otherNames>Walker TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>545917f270f2e8.56879472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E45F520-18D5-4202-9101-10C0DBC479D6</gtr:id><gtr:title>Contact investigations for outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing.</gtr:title><gtr:parentPublicationTitle>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b28d0b8d761f7bc1fdd65850bb4ea8f"><gtr:id>8b28d0b8d761f7bc1fdd65850bb4ea8f</gtr:id><gtr:otherNames>Walker TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1198-743X</gtr:issn><gtr:outcomeId>B94xFipgkVk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>144565A9-5ADA-4766-8499-98F6D79FD8DC</gtr:id><gtr:title>Genomics and outbreak investigation: from sequence to consequence.</gtr:title><gtr:parentPublicationTitle>Genome medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de982570112871dfeb09d3eb57d6b4e0"><gtr:id>de982570112871dfeb09d3eb57d6b4e0</gtr:id><gtr:otherNames>Robinson ER</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1756-994X</gtr:issn><gtr:outcomeId>pm_13652_22_23673226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDED80A7-7929-4CFE-82B8-3B6B8295ACB9</gtr:id><gtr:title>Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3c5aeb92de5f9eef2a603f8b6d2dded"><gtr:id>f3c5aeb92de5f9eef2a603f8b6d2dded</gtr:id><gtr:otherNames>Bradley P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56d9df4db79633.43768190</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F040414A-01BC-43A6-8EF3-04C5F8AC7BE0</gtr:id><gtr:title>Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b28d0b8d761f7bc1fdd65850bb4ea8f"><gtr:id>8b28d0b8d761f7bc1fdd65850bb4ea8f</gtr:id><gtr:otherNames>Walker TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>56d9df4d985221.32042894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43EB1D39-BAC7-4D79-822D-139E635C8144</gtr:id><gtr:title>Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b28d0b8d761f7bc1fdd65850bb4ea8f"><gtr:id>8b28d0b8d761f7bc1fdd65850bb4ea8f</gtr:id><gtr:otherNames>Walker TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>C2R6Fpukf38</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J011398/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>